人工智能辅助软件显著降低了大型辐辏系统中大血管闭塞转运患者的所有工作流程指标。

IF 2 Q3 PERIPHERAL VASCULAR DISEASE Cerebrovascular Diseases Extra Pub Date : 2023-01-01 Epub Date: 2023-02-14 DOI:10.1159/000529077
Stavros Matsoukas, Laura K Stein, Johanna Fifi
{"title":"人工智能辅助软件显著降低了大型辐辏系统中大血管闭塞转运患者的所有工作流程指标。","authors":"Stavros Matsoukas, Laura K Stein, Johanna Fifi","doi":"10.1159/000529077","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Artificial intelligence (AI) software is increasingly applied in stroke diagnostics. Viz LVO (large vessel occlusion) is an AI-based software that is FDA-approved for LVO detection in CT angiography (CTA) scans. We sought to investigate differences in transfer times (from peripheral [spoke] to central [hub] hospitals) for LVO patients between spoke hospitals that utilize Viz LVO and those that do not.</p><p><strong>Methods: </strong>In this retrospective cohort study, we used our institutional database to identify all suspected/confirmed LVO-transferred patients from spokes (peripheral hospitals) within and outside of our healthcare system, from January 2020 to December 2021. The \"Viz-transfers\" group includes all LVO transfers from spokes within our system where Viz LVO is readily available, while the \"Non-Viz-transfers\" group (control group) is comprised of all LVO transfers from spokes outside our system, without Viz LVO. Primary outcome included all available time metrics from peripheral CTA commencement.</p><p><strong>Results: </strong>In total, 78 patients required a transfer. Despite comparable peripheral hospital door to peripheral hospital CTA times (20.5 [24.3] vs. 32 [45] min, p = 0.28) and transfer (spoke to hub) time (23 [18] vs. 26 [13.5], p = 0.763), all workflow metrics were statistically significantly shorter in the Viz-transfers group. Peripheral CTA to interventional neuroradiology team notification was 12 (16.8) versus 58 (59.5), p &lt; 0.001, and peripheral CTA to peripheral departure was 91.5 (37) versus 122.5 (68.5), p &lt; 0.001. Peripheral arrival to peripheral departure was 116.5 (75.5) versus 169 (126.8), p = 0.002, and peripheral arrival to central arrival was 145 (62.5) versus 207 (97.8), p &lt; 0.001. In addition, peripheral CTA to angiosuite arrival was 121 (41) versus 207 (92.5), p &lt; 0.001, peripheral CTA to arterial puncture was 146 (53) versus 234 (99.8), p &lt; 0.001, and peripheral CTA to recanalization was 198 (25) versus 253.5 (86), p &lt; 0.001.</p><p><strong>Conclusion: </strong>Within our spoke and hub system, Viz LVO significantly decreased all workflow metrics for patients who were transferred from spokes with versus without Viz.</p>","PeriodicalId":45709,"journal":{"name":"Cerebrovascular Diseases Extra","volume":" ","pages":"41-46"},"PeriodicalIF":2.0000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/5b/1c/cee-2023-0013-0001-529077.PMC9999083.pdf","citationCount":"0","resultStr":"{\"title\":\"Artificial Intelligence-Assisted Software Significantly Decreases All Workflow Metrics for Large Vessel Occlusion Transfer Patients, within a Large Spoke and Hub System.\",\"authors\":\"Stavros Matsoukas, Laura K Stein, Johanna Fifi\",\"doi\":\"10.1159/000529077\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Introduction: </strong>Artificial intelligence (AI) software is increasingly applied in stroke diagnostics. Viz LVO (large vessel occlusion) is an AI-based software that is FDA-approved for LVO detection in CT angiography (CTA) scans. We sought to investigate differences in transfer times (from peripheral [spoke] to central [hub] hospitals) for LVO patients between spoke hospitals that utilize Viz LVO and those that do not.</p><p><strong>Methods: </strong>In this retrospective cohort study, we used our institutional database to identify all suspected/confirmed LVO-transferred patients from spokes (peripheral hospitals) within and outside of our healthcare system, from January 2020 to December 2021. The \\\"Viz-transfers\\\" group includes all LVO transfers from spokes within our system where Viz LVO is readily available, while the \\\"Non-Viz-transfers\\\" group (control group) is comprised of all LVO transfers from spokes outside our system, without Viz LVO. Primary outcome included all available time metrics from peripheral CTA commencement.</p><p><strong>Results: </strong>In total, 78 patients required a transfer. Despite comparable peripheral hospital door to peripheral hospital CTA times (20.5 [24.3] vs. 32 [45] min, p = 0.28) and transfer (spoke to hub) time (23 [18] vs. 26 [13.5], p = 0.763), all workflow metrics were statistically significantly shorter in the Viz-transfers group. Peripheral CTA to interventional neuroradiology team notification was 12 (16.8) versus 58 (59.5), p &lt; 0.001, and peripheral CTA to peripheral departure was 91.5 (37) versus 122.5 (68.5), p &lt; 0.001. Peripheral arrival to peripheral departure was 116.5 (75.5) versus 169 (126.8), p = 0.002, and peripheral arrival to central arrival was 145 (62.5) versus 207 (97.8), p &lt; 0.001. In addition, peripheral CTA to angiosuite arrival was 121 (41) versus 207 (92.5), p &lt; 0.001, peripheral CTA to arterial puncture was 146 (53) versus 234 (99.8), p &lt; 0.001, and peripheral CTA to recanalization was 198 (25) versus 253.5 (86), p &lt; 0.001.</p><p><strong>Conclusion: </strong>Within our spoke and hub system, Viz LVO significantly decreased all workflow metrics for patients who were transferred from spokes with versus without Viz.</p>\",\"PeriodicalId\":45709,\"journal\":{\"name\":\"Cerebrovascular Diseases Extra\",\"volume\":\" \",\"pages\":\"41-46\"},\"PeriodicalIF\":2.0000,\"publicationDate\":\"2023-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/5b/1c/cee-2023-0013-0001-529077.PMC9999083.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Cerebrovascular Diseases Extra\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1159/000529077\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2023/2/14 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q3\",\"JCRName\":\"PERIPHERAL VASCULAR DISEASE\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cerebrovascular Diseases Extra","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1159/000529077","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2023/2/14 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"PERIPHERAL VASCULAR DISEASE","Score":null,"Total":0}
引用次数: 0

摘要

简介:人工智能(AI)软件越来越多地应用于脑卒中诊断:人工智能(AI)软件越来越多地应用于中风诊断。Viz LVO(大血管闭塞)是一款基于人工智能的软件,经 FDA 批准用于 CT 血管造影 (CTA) 扫描中的 LVO 检测。我们试图调查使用 Viz LVO 的辐条医院与未使用 Viz LVO 的辐条医院之间 LVO 患者转院时间(从外围辐条医院到中心辐条医院)的差异:在这项回顾性队列研究中,我们利用本机构的数据库,识别了从 2020 年 1 月至 2021 年 12 月期间医疗系统内外辐条(外围医院)转运的所有疑似/确诊 LVO 患者。Viz-转运 "组包括从本系统内可随时使用 Viz LVO 的辐条转运的所有 LVO 患者,而 "非 Viz-转运 "组(对照组)则包括从本系统外没有 Viz LVO 的辐条转运的所有 LVO 患者。主要结果包括从外周 CTA 开始的所有可用时间指标:共有 78 名患者需要转院。尽管外围医院门到外围医院CTA时间(20.5 [24.3] 分钟 vs. 32 [45] 分钟,p = 0.28)和转运(辐条到枢纽)时间(23 [18] 分钟 vs. 26 [13.5]分钟,p = 0.763)相当,但Viz转运组的所有工作流程指标在统计学上都显著缩短。外周 CTA 到介入神经放射团队的通知时间为 12 (16.8) 对 58 (59.5),p < 0.001;外周 CTA 到外周离开的时间为 91.5 (37) 对 122.5 (68.5),p < 0.001。外周到达到外周离开为 116.5(75.5)对 169(126.8),p = 0.002,外周到达到中心到达为 145(62.5)对 207(97.8),p <0.001。此外,外周 CTA 到达血管穿刺点为 121(41)对 207(92.5),p <0.001;外周 CTA 到达动脉穿刺点为 146(53)对 234(99.8),p <0.001;外周 CTA 到达再通路为 198(25)对 253.5(86),p <0.001:在我们的辐条和枢纽系统中,Viz LVO 显著降低了从有 Viz 的辐条和无 Viz 的辐条转运的患者的所有工作流程指标。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

摘要图片

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Artificial Intelligence-Assisted Software Significantly Decreases All Workflow Metrics for Large Vessel Occlusion Transfer Patients, within a Large Spoke and Hub System.

Introduction: Artificial intelligence (AI) software is increasingly applied in stroke diagnostics. Viz LVO (large vessel occlusion) is an AI-based software that is FDA-approved for LVO detection in CT angiography (CTA) scans. We sought to investigate differences in transfer times (from peripheral [spoke] to central [hub] hospitals) for LVO patients between spoke hospitals that utilize Viz LVO and those that do not.

Methods: In this retrospective cohort study, we used our institutional database to identify all suspected/confirmed LVO-transferred patients from spokes (peripheral hospitals) within and outside of our healthcare system, from January 2020 to December 2021. The "Viz-transfers" group includes all LVO transfers from spokes within our system where Viz LVO is readily available, while the "Non-Viz-transfers" group (control group) is comprised of all LVO transfers from spokes outside our system, without Viz LVO. Primary outcome included all available time metrics from peripheral CTA commencement.

Results: In total, 78 patients required a transfer. Despite comparable peripheral hospital door to peripheral hospital CTA times (20.5 [24.3] vs. 32 [45] min, p = 0.28) and transfer (spoke to hub) time (23 [18] vs. 26 [13.5], p = 0.763), all workflow metrics were statistically significantly shorter in the Viz-transfers group. Peripheral CTA to interventional neuroradiology team notification was 12 (16.8) versus 58 (59.5), p < 0.001, and peripheral CTA to peripheral departure was 91.5 (37) versus 122.5 (68.5), p < 0.001. Peripheral arrival to peripheral departure was 116.5 (75.5) versus 169 (126.8), p = 0.002, and peripheral arrival to central arrival was 145 (62.5) versus 207 (97.8), p < 0.001. In addition, peripheral CTA to angiosuite arrival was 121 (41) versus 207 (92.5), p < 0.001, peripheral CTA to arterial puncture was 146 (53) versus 234 (99.8), p < 0.001, and peripheral CTA to recanalization was 198 (25) versus 253.5 (86), p < 0.001.

Conclusion: Within our spoke and hub system, Viz LVO significantly decreased all workflow metrics for patients who were transferred from spokes with versus without Viz.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Cerebrovascular Diseases Extra
Cerebrovascular Diseases Extra PERIPHERAL VASCULAR DISEASE-
CiteScore
3.50
自引率
0.00%
发文量
16
审稿时长
8 weeks
期刊介绍: This open access and online-only journal publishes original articles covering the entire spectrum of stroke and cerebrovascular research, drawing from a variety of specialties such as neurology, internal medicine, surgery, radiology, epidemiology, cardiology, hematology, psychology and rehabilitation. Offering an international forum, it meets the growing need for sophisticated, up-to-date scientific information on clinical data, diagnostic testing, and therapeutic issues. The journal publishes original contributions, reviews of selected topics as well as clinical investigative studies. All aspects related to clinical advances are considered, while purely experimental work appears only if directly relevant to clinical issues. Cerebrovascular Diseases Extra provides additional contents based on reviewed and accepted submissions to the main journal Cerebrovascular Diseases.
期刊最新文献
Safety and Efficacy of Thrombectomy in Vietnamese Stroke Patients Selected Through Perfusion Imaging With an Onset Time Between 6-24 Hours. Intracerebral hemorrhage. Clinical Profile of Stroke Chameleons Receiving Intravenous Thrombolysis: Insights from a Single-Center Experience. Waveform Analysis of STA-MCA Bypass graft in Revascularization Surgery for Moyamoya Disease. Predictors for Adherence to Recommended Anticoagulation after Stroke Unit Discharge in Patients with Atrial Fibrillation.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1